Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin

Join us for a powerful message of hope and perseverance after a cancer diagnosis. In this episode, Rashad Hayes shares

Navigating the maze of cancer care can be overwhelming. Join us as Sara Grisales Jaramillo, LMSW, of CancerCare discusses the

Please join us for this special episode live from CancerCon, a young adult cancer conference presented by Stupid Cancer. A

There are new Medicare changes starting in January 2025 that will benefit cancer patients. LLS Vice President of Federal

Please join us for this special episode live from CancerCon, a young adult cancer conference presented by Stupid Cancer. Following

Please join us for this special episode live from CancerCon, a young adult cancer conference presented by Stupid Cancer. Following

Living with chronic lymphocytic leukemia (CLL) can be a challenging journey for both patients and caregivers. However, there is a

Chronic myelomonocytic leukemia (CMML) has been a challenging disease to tackle, historically treated with therapies meant for other conditions. But

The treatment landscape for non-Hodgkin lymphoma has significantly evolved over the past few decades. With groundbreaking advancements in CAR T-cell